| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1365-2796.2012.02525.X |
| P698 | PubMed publication ID | 22292490 |
| P50 | author | Gareth Evans | Q29642643 |
| Jane Warwick | Q55113202 | ||
| Jamie C Sergeant | Q57058616 | ||
| Anthony Howell | Q37828919 | ||
| William G. Newman | Q38545164 | ||
| Iain Buchan | Q47503095 | ||
| P2093 | author name string | M Wilson | |
| J Cuzick | |||
| R Warren | |||
| S Sahin | |||
| S Ingham | |||
| M Harvie | |||
| P Stavrinos | |||
| S Astley | |||
| B Eckersley | |||
| U Beetles | |||
| A Hufton | |||
| H McBurney | |||
| P2860 | cites work | Survival analysis of cancer risk reduction strategies for BRCA1/2 mutation carriers | Q24654487 |
| Global cancer statistics, 2002 | Q27860562 | ||
| Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women | Q28251695 | ||
| Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study | Q28281843 | ||
| Long-term results of tamoxifen prophylaxis for breast cancer--96-month follow-up of the randomized IBIS-I trial | Q28289262 | ||
| Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial | Q28296300 | ||
| A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer | Q28303909 | ||
| Prevention of breast cancer in postmenopausal women: approaches to estimating and reducing risk | Q28390064 | ||
| Validation studies for models projecting the risk of invasive and total breast cancer incidence. | Q50651945 | ||
| Breast cancer risk assessment in the Czech female population--an adjustment of the original Gail model. | Q51830214 | ||
| Projecting absolute invasive breast cancer risk in white women with a model that includes mammographic density. | Q51933968 | ||
| A breast cancer prediction model incorporating familial and personal risk factors. | Q52000310 | ||
| Gail Model for Prediction of Absolute Risk of Invasive Breast Cancer: Independent Evaluation in the Florence–European Prospective Investigation Into Cancer and Nutrition Cohort | Q56836342 | ||
| Mammographic surveillance in women younger than 50 years who have a family history of breast cancer: tumour characteristics and projected effect on mortality in the prospective, single-arm, FH01 study | Q57266615 | ||
| Addition of pathology and biomarker information significantly improves the performance of the Manchester scoring system for BRCA1 and BRCA2 testing | Q57266657 | ||
| Screening younger women with a family history of breast cancer – does early detection improve outcome? | Q57266725 | ||
| Cancer genetics clinics | Q57266922 | ||
| Critical assessment of new risk factors for breast cancer: considerations for development of an improved risk prediction model | Q30444093 | ||
| Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention | Q32133889 | ||
| Mammographic density | Q33555460 | ||
| Gene-environment interactions in 7610 women with breast cancer: prospective evidence from the Million Women Study | Q33935171 | ||
| Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers | Q33958285 | ||
| Incorporating tumour pathology information into breast cancer risk prediction algorithms | Q34048046 | ||
| Women's reproductive cancers in evolutionary context | Q34059844 | ||
| Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing breast cancer | Q34110074 | ||
| Genome-wide association study identifies five new breast cancer susceptibility loci | Q34114293 | ||
| Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality | Q34135443 | ||
| Assessment of clinical validity of a breast cancer risk model combining genetic and clinical information | Q34267477 | ||
| Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2 | Q34384153 | ||
| Single reading with computer-aided detection and double reading of screening mammograms in the United Kingdom National Breast Screening Program. | Q34567892 | ||
| Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study | Q34613673 | ||
| Interval cancers in the NHS breast cancer screening programme in England, Wales and Northern Ireland | Q34627966 | ||
| Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer | Q34631785 | ||
| Benefit/risk assessment for breast cancer chemoprevention with raloxifene or tamoxifen for women age 50 years or older | Q35023437 | ||
| Overview of the main outcomes in breast-cancer prevention trials | Q35057371 | ||
| Volume of mammographic density and risk of breast cancer | Q35093794 | ||
| Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme | Q35441054 | ||
| A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPRO | Q35445946 | ||
| Discriminatory accuracy and potential clinical utility of genomic profiling for breast cancer risk in BRCA-negative women | Q35846927 | ||
| Estimation of effect size distribution from genome-wide association studies and implications for future discoveries | Q36191121 | ||
| Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis | Q36507079 | ||
| The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions | Q36615665 | ||
| Discriminatory accuracy from single-nucleotide polymorphisms in models to predict breast cancer risk | Q36858843 | ||
| Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model | Q37172219 | ||
| Value of adding single-nucleotide polymorphism genotypes to a breast cancer risk model | Q37246495 | ||
| Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1. | Q37369631 | ||
| Predicting the future of genetic risk prediction | Q37733169 | ||
| Assessing women at high risk of breast cancer: a review of risk assessment models | Q37739036 | ||
| Interpreting the epidemiological evidence linking obesity and cancer: A framework for population-attributable risk estimations in Europe. | Q37789067 | ||
| Genome-based prediction of breast cancer risk in the general population: a modeling study based on meta-analyses of genetic associations | Q37826562 | ||
| Physical activity and breast cancer: review of the epidemiologic evidence and biologic mechanisms | Q37831205 | ||
| Preventive therapy for breast cancer: a consensus statement | Q37858249 | ||
| Does intentional weight loss reduce cancer risk? | Q37898177 | ||
| Population-based study of changing breast cancer risk in Icelandic BRCA2 mutation carriers, 1920-2000. | Q38469992 | ||
| Weight loss and postmenopausal breast cancer in a prospective cohort of overweight and obese US women | Q39782269 | ||
| Familial breast cancer. | Q40816647 | ||
| IBIS II: a breast cancer prevention trial in postmenopausal women using the aromatase inhibitor anastrozole | Q44134557 | ||
| Tumor characteristics associated with mammographic detection of breast cancer in the Ontario breast screening program | Q44609406 | ||
| Continuing outcomes relevant to Evista: breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene | Q45168977 | ||
| Predicting risk of breast cancer in postmenopausal women by hormone receptor status | Q46901894 | ||
| Dual effects of weight and weight gain on breast cancer risk | Q47300501 | ||
| Adult weight change and risk of postmenopausal breast cancer | Q47330282 | ||
| Association of gain and loss of weight before and after menopause with risk of postmenopausal breast cancer in the Iowa women's health study | Q47388619 | ||
| Exemestane for breast-cancer prevention in postmenopausal women. | Q48657440 | ||
| Validation of the Gail et al. model for predicting individual breast cancer risk. | Q50603613 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 321-330 | |
| P577 | publication date | 2012-04-01 | |
| P1433 | published in | Journal of Internal Medicine | Q6295387 |
| P1476 | title | Prevention of breast cancer in the context of a national breast screening programme | |
| P478 | volume | 271 |
| Q28069307 | Beyond breast density: a review on the advancing role of parenchymal texture analysis in breast cancer risk assessment |
| Q53119392 | Correcting for rater bias in scores on a continuous scale, with application to breast density. |
| Q28364666 | Digital mammographic density and breast cancer risk: a case-control study of six alternative density assessment methods |
| Q52682549 | Disentangling the determinants of interest and willingness-to-pay for breast cancer susceptibility testing in the general population: a cross-sectional Web-based survey among women of Québec (Canada). |
| Q28084601 | Do Health Professionals Need Additional Competencies for Stratified Cancer Prevention Based on Genetic Risk Profiling? |
| Q89799256 | Envisioning Implementation of a Personalized Approach in Breast Cancer Screening Programs: Stakeholder Perspectives |
| Q26825771 | Implementing risk-stratified screening for common cancers: a review of potential ethical, legal and social issues |
| Q37614763 | Incorporating genomics into breast and prostate cancer screening: assessing the implications |
| Q36583004 | Prediction of breast cancer risk based on profiling with common genetic variants |
| Q34811135 | Public health genomics and personalized prevention: lessons from the COGS project |
| Q37524981 | Recommendations on breast cancer screening and prevention in the context of implementing risk stratification: impending changes to current policies |
| Q36112872 | Relationship of Predicted Risk of Developing Invasive Breast Cancer, as Assessed with Three Models, and Breast Cancer Mortality among Breast Cancer Patients |
| Q39458551 | What ethical and legal principles should guide the genotyping of children as part of a personalised screening programme for common cancer? |
Search more.